Panacea Biotec Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 18, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	32,855	18,133	27,027	7,445	6,643	9,077
Market Cap Growth	1.11%	-32.91%	263.02%	12.08%	-26.82%	-17.16%
Enterprise Value	31,685	17,035	25,428	5,776	3,942	15,905
Last Close Price	535.35	296.15	440.65	121.30	108.35	148.25
PE Ratio	-	-	-	-	-	0.84
PS Ratio	5.14	2.83	4.83	1.33	1.44	1.37
PB Ratio	3.96	2.19	3.25	0.89	0.79	1.04
P/TBV Ratio	4.19	2.31	3.48	0.94	0.82	1.08
P/OCF Ratio	196.97	108.71	-	214.68	-	-
EV/Sales Ratio	4.95	2.66	4.55	1.03	0.86	2.40
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.02	0.04
Net Debt / Equity Ratio	-0.06	-0.06	-0.13	-0.16	-0.23	-0.59
Net Debt / EBITDA Ratio	10.89	10.89	5.16	17.91	3.01	91.95
Net Debt / FCF Ratio	1.36	1.36	1.38	1.64	0.42	4.28
Asset Turnover	0.50	0.50	0.44	0.45	0.30	0.45
Inventory Turnover	1.38	1.38	1.02	1.21	1.22	1.36
Quick Ratio	0.42	0.42	0.55	0.68	0.83	0.82
Current Ratio	1.47	1.47	1.49	1.57	1.71	1.28
Return on Equity (ROE)	-0.86%	-0.86%	-1.04%	-0.18%	-3.94%	335.95%
Return on Assets (ROA)	-1.85%	-1.85%	-2.62%	-2.06%	-4.24%	-2.06%
Return on Invested Capital (ROIC)	-5.05%	-5.02%	-7.40%	6.24%	53.96%	-8.45%
Return on Capital Employed (ROCE)	-4.10%	-4.10%	-5.70%	-4.50%	-10.90%	-4.90%
Earnings Yield	-0.16%	-0.30%	-0.31%	-0.16%	-5.00%	118.79%
FCF Yield	-1.14%	-2.06%	-2.87%	-10.67%	-69.76%	-13.33%
Buyback Yield / Dilution	0.37%	0.37%	-	-	-	-